APA (7th ed.) Citation

Saulnier-Sholler, G., Duda, D. G., Bergendahl, G., Ebb, D., Snuderl, M., Laetsch, T. W., . . . Jain, R. K. (2022). A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma. Clinical cancer research, 28(18), 3950-3957. https://doi.org/10.1158/1078-0432.CCR-22-1169

Chicago Style (17th ed.) Citation

Saulnier-Sholler, Giselle, et al. "A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma." Clinical Cancer Research 28, no. 18 (2022): 3950-3957. https://doi.org/10.1158/1078-0432.CCR-22-1169.

MLA (9th ed.) Citation

Saulnier-Sholler, Giselle, et al. "A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma." Clinical Cancer Research, vol. 28, no. 18, 2022, pp. 3950-3957, https://doi.org/10.1158/1078-0432.CCR-22-1169.